These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4075170)

  • 1. Regional saturation studies of [3H]naloxone binding in the naive, dependent and withdrawal states.
    Geary WA; Wooten GF
    Brain Res; 1985 Dec; 360(1-2):214-23. PubMed ID: 4075170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain.
    Geary WA; Wooten GF
    J Pharmacol Exp Ther; 1983 Apr; 225(1):234-40. PubMed ID: 6300375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo binding of naloxone to opioid receptors in morphine-dependent mice.
    Oishi R; Ozaki M; Takemori AE
    Neuropharmacology; 1983 Aug; 22(8):1015-9. PubMed ID: 6312358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists.
    Valentino RJ; Katz JL; Medzihradsky F; Woods JH
    Life Sci; 1983 Jun; 32(25):2887-96. PubMed ID: 6304445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats.
    Bhargava HN; Das S; Bansinath M; Prasad R
    Pharmacol Biochem Behav; 1989 Sep; 34(1):7-12. PubMed ID: 2516632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between incorporation of choline into phosphatidylcholine and morphine binding sites.
    Natsuki R
    Arukoru Kenkyuto Yakubutsu Ison; 1992 Feb; 27(1):57-70. PubMed ID: 1317702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
    Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
    Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonidine attenuates increased brain glucose metabolism during naloxone-precipitated morphine withdrawal.
    Kimes AS; Bell JA; London ED
    Neuroscience; 1990; 34(3):633-44. PubMed ID: 2352645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of morphine tolerance and abstinence on the binding of [3H]MK-801 to brain regions and spinal cord of the rat.
    Gudehithlu KP; Reddy PL; Bhargava HN
    Brain Res; 1994 Mar; 639(2):269-74. PubMed ID: 7911390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal.
    Ozawa T; Nakagawa T; Shige K; Minami M; Satoh M
    Brain Res; 2001 Jun; 905(1-2):254-8. PubMed ID: 11423104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in alpha 2-adrenoceptor binding nature in guinea-pig brain following the development of morphine dependence].
    Ohta S; Niwa M; Nozaki M; Asano T; Takeda T; Dohi S
    Masui; 1997 May; 46(5):640-3. PubMed ID: 9185461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine release and displacement by naloxone in vivo in morphine naive and withdrawn rats.
    Dwoskin LP; Sprague GL; Takemori AE; Sparber SB
    Life Sci; 1980 Feb; 26(5):377-85. PubMed ID: 7189229
    [No Abstract]   [Full Text] [Related]  

  • 13. Naloxone-precipitated withdrawal reveals sensitization to neurotransmitters in morphine tolerant/dependent rats.
    Schulz R; Herz A
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Aug; 299(1):95-9. PubMed ID: 20584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo tracer studies of glucose metabolism, cerebral blood flow, and protein synthesis in naloxone precipitated morphine withdrawal.
    Geary WA; Wooten GF
    Neurochem Res; 1987 Jul; 12(7):573-80. PubMed ID: 3614509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of morphine withdrawal on cerebral beta 1- and beta 2-adrenergic receptors.
    Kuriyama K; Muramatsu M; Ohkuma S; Tamura J; Ping ZP
    J Neurosci Res; 1981; 6(6):749-55. PubMed ID: 6278157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of synaptic high and low affinity opiate binding sites after acute and chronic morphine administration in mice.
    Sivam SP; Nabeshima T; Ho IK
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(2):119-27. PubMed ID: 6287530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of D1 and D2 dopaminergic receptor kinetics in specific rat brain regions following repeated administration of opiates.
    Elwan MA; Soliman MR
    Pharmacology; 1995 Aug; 51(2):73-83. PubMed ID: 8584575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acute and chronic morphine administration on brain cholinergic muscarinic receptors.
    Das S; Matwyshyn GA; Bhargava HN
    Gen Pharmacol; 1986; 17(2):173-8. PubMed ID: 3699442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
    Windh RT; Little PJ; Kuhn CM
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding of 3H-quinuclidinyl benzilate to cholinergic muscarinic receptors in rat brain region following chronic treatment with morphine and during abstinence.
    Das S; Matwyshyn GA; Bhargava HN
    Neuropeptides; 1984 Dec; 5(1-3):45-8. PubMed ID: 6543385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.